KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Assets: 2018-2025

Historic Return on Assets for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Sep 2025 value amounting to 0.15%.

  • Aurinia Pharmaceuticals' Return on Assets rose 19.00% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 19.00%. This contributed to the annual value of 0.01% for FY2024, which is 16.00% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Return on Assets stood at 0.15%, which was up 25.61% from 0.12% recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Return on Assets peaked at 0.15% during Q3 2025, and registered a low of -0.42% during Q3 2021.
  • For the 3-year period, Aurinia Pharmaceuticals' Return on Assets averaged around -0.05%, with its median value being -0.10% (2024).
  • In the last 5 years, Aurinia Pharmaceuticals' Return on Assets decreased by 18bps in 2021 and then climbed by 22bps in 2025.
  • Aurinia Pharmaceuticals' Return on Assets (Quarterly) stood at -0.40% in 2021, then grew by 18bps to -0.23% in 2022, then grew by 8bps to -0.14% in 2023, then climbed by 15bps to 0.01% in 2024, then grew by 19bps to 0.15% in 2025.
  • Its Return on Assets was 0.15% in Q3 2025, compared to 0.12% in Q2 2025 and 0.08% in Q1 2025.